Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Scientists at Malmo University publish research in breast cancer
April 3rd, 2008
According to recent research from Malmo, Sweden, "The majority of all breast cancers are hormone responsive, traditionally defined by the expression of oestrogen receptor (ER) alpha and/or progesterone receptors. In contrast to ER alpha, the clinical significance of the relatively recently identified ER beta is still unclear." "This study aimed to define the relationship between ER beta and clinicopathological parameters in a mixed cohort of breast cancer and, furthermore, to investigate the impact of ER beta expression on disease outcome. The immunohistochemical expression of ER alpha and ER beta was analysed in tissue microarrays containing a total number of 512...
Source: Women's Health Weekly (2008-04-03)
|
